![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Overall Survival Data Presented at ASCO 2020 for nmCRPC (OncLive) View |
![]() |
ASCO20 - PROSPER Trial Data - Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) (HPR) View |
![]() |
Updated overall survival outcomes in ENZAMET (ANZUP 1304) (European Association of Urology) View |
![]() |
Impact of Clinical Data on the Treatment of mCRPC (OncLive) View |
![]() |
MONARCH 2: Overall survival of abemaciclib plus fulvestrant in HR+, HER2- advanced breast cancer (Oncoletter) View |
![]() |
Apalutamide in combination with abiraterone acetate, docetaxel and prednisone for mCRPC (VJOncology) View |
![]() |
Student Virtual Journal Club - Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer (Study Rx) View |
![]() |
TITAN trial (European Association of Urology) View |
![]() |
M0 CRPC: Treatment Options and Goals of Therapy (AUAUniversity) View |
![]() |
Case 1: Patient Choice in Initiating AR-Targeted Therapy in nmCRPC (Targeted Oncology) View |